During tumor development, the highly expressed PD-L1 molecules on tumor cells bind to the PD-1 and B7.1 receptors on the surface of activated T cells, leading to the differentiation of T cells into depleted T cells or regulatory T cells. This evidence concerns the gene CD274 and neoplasm.